Your browser doesn't support javascript.
CoronaVac efficacy data from Turkey - Authors' reply.
Tanriover, Mine Durusu; Doganay, Hamdi Levent; Unal, Serhat; Akova, Murat.
  • Tanriover MD; Department of Internal Medicine, Hacettepe University School of Medicine, Ankara 06230, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey.
  • Doganay HL; Department of Gastroenterology, Turkish Republic Ministry of Health, Istanbul Provincial Health Directorate, University of Health Sciences Istanbul Umraniye Training and Research Hospital, Istanbul, Turkey.
  • Unal S; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara 06230, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey.
  • Akova M; Department of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara 06230, Turkey; Hacettepe University Vaccine Institute, Ankara, Turkey. Electronic address: makova@hacettepe.edu.tr.
Lancet ; 398(10314): 1874, 2021 11 20.
Article in English | MEDLINE | ID: covidwho-1519991
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / Antibodies, Viral Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)02286-8

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / Antibodies, Viral Topics: Vaccines Limits: Humans Country/Region as subject: Asia Language: English Journal: Lancet Year: 2021 Document Type: Article Affiliation country: S0140-6736(21)02286-8